Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.920
-0.030 (-0.76%)
At close: Sep 15, 2025, 4:00 PM EDT
3.920
0.00 (0.01%)
After-hours: Sep 15, 2025, 5:15 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $146.37 million as of September 15, 2025. Its market cap has increased by 116.78% in one year.
Market Cap
146.37M
Enterprise Value
120.11M
1-Year Change
116.78%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $146.37M, an increase of 3.30%. That is a compound annual growth rate of 1.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 146.37M | 81.86% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |